-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JXWDHqudatBCWJNj6hOuz1DJldR+TXld3Q7nYdgm+Izj18wb4caQwGUlJoPOKCoE YCF5Vg97hFZqRZb+i3zxJQ== 0001013762-10-002496.txt : 20101021 0001013762-10-002496.hdr.sgml : 20101021 20101021171810 ACCESSION NUMBER: 0001013762-10-002496 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101015 ITEM INFORMATION: Other Events FILED AS OF DATE: 20101021 DATE AS OF CHANGE: 20101021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN SCIENTIFICS INC CENTRAL INDEX KEY: 0001099132 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 850460639 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28411 FILM NUMBER: 101135567 BUSINESS ADDRESS: STREET 1: 405 LEXINGTON AVENUE STREET 2: 32ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10174 BUSINESS PHONE: 2125510577 MAIL ADDRESS: STREET 1: 405 LEXINGTON AVENUE STREET 2: 32ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10174 8-K 1 form8k.htm MANHATTAN SCIENTIFICS FORM 8-K form8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
 
Current Report
 
Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): October 15, 2010
 
MANHATTAN SCIENTIFICS, INC.
(Name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
Incorporation or organization)
 
405 Lexington Avenue, 32nd Floor
New York, New York
(Address of principal executive offices)
000-28411
(Commission File Number)
85-0460639
(I.R.S. Employer
Identification Number)
 
 
10174
(Zip Code)

Registrant’s telephone number, including area code: (212) 551-0577
 
N/A
(Former name or former address, if changed since last report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

 
 
Item 8.01.
 
Other Events.
 
Manhattan Scientifics, Inc. (the “Company”) received confirmation from Carpenter Technology Corporation (“Carpenter”) that the Company has satisfied its performance obligations under paragraph 5.4 of the Technology Transfer Agreement between the parties dated August 12, 2009 (attached to Form 10-Q/A filed on October 4, 2010) (the Agreement”). As a result, the Company received a payment from Carpenter on October 15, 2010, in the amount of $1,000,000, as required by paragraph 8.1.2 of the Agreement.

 
 
 
 
 

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
MANHATTAN SCIENTIFICS, INC.
 
       
Date: October 21, 2010 
By:
/s/ Emmanuel Tsoupanarias  
    Name:   Emmanuel Tsoupanarias  
    Title:           Chief Executive Officer  
       



 
-----END PRIVACY-ENHANCED MESSAGE-----